Results 311 to 320 of about 151,016 (323)
Some of the next articles are maybe not open access.
The paroxysm of Plasmodium vivax malaria
Trends in Parasitology, 2003The paroxysms of Plasmodium vivax malaria are antiparasite responses that, although distressing to the human host, almost never impart serious acute pathology. Using plasma and blood cells from P. vivax patients, the cellular and noncellular mediators of these events have been studied ex vivo. The host response during a P.
Richard Carter +4 more
openaire +3 more sources
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
The Lancet, 1989Two soldiers continued weekly prophylaxis with 300 mg chloroquine base on their return to Australia from Papua New Guinea but were not protected against Plasmodium vivax malaria. Both had symptoms and parasitaemia although plasma concentrations of chloroquine were considerably higher than those regarded as adequate for suppression of vivax malaria ...
D.C. Hutton +2 more
openaire +3 more sources
Primaquine Resistance in Plasmodium vivax
The American Journal of Tropical Medicine and Hygiene, 1996Reports have appeared calling attention to what has been termed primaquine resistance in Plasmodium vivax in several geographic areas. The possibility exists that primaquine tolerant strains (often referred to as the tropical zone type from the South Pacific and Southeast Asian regions characterized by early and frequent relapses) may have become ...
Geoffrey M. Jeffery, William E. Collins
openaire +3 more sources
2016
Of the five species of malaria parasites infecting humans, Plasmodium vivax has the widest global distribution, with more than 80 million people infected each year (Price et al. Am J Trop Med Hyg 77:79–87, 2007) and 2.5 billion people at risk (Gething et al. PLoS Negl Trop Dis 6:e1814, 2012).
Moses Laman +3 more
openaire +2 more sources
Of the five species of malaria parasites infecting humans, Plasmodium vivax has the widest global distribution, with more than 80 million people infected each year (Price et al. Am J Trop Med Hyg 77:79–87, 2007) and 2.5 billion people at risk (Gething et al. PLoS Negl Trop Dis 6:e1814, 2012).
Moses Laman +3 more
openaire +2 more sources
The periodicity of Plasmodium vivax and Plasmodium falciparum in Venezuela
Acta Tropica, 2014We investigated the periodicity of Plasmodium vivax and P. falciparum incidence in time-series of malaria data (1990-2010) from three endemic regions in Venezuela. In particular, we determined whether disease epidemics were related to local climate variability and regional climate anomalies such as the El Niño Southern Oscillation (ENSO).
María-Eugenia Grillet +3 more
openaire +3 more sources
Control and Elimination of Plasmodium vivax
2012Plasmodium vivax represents a special challenge to malaria control because of the ability of a single infection to relapse over months to years. P. vivax is more tolerant of low temperatures than P. falciparum, which spreads its potential range far beyond the tropics into sub-Arctic areas.
openaire +4 more sources
Plasmodium vivax malaria in the UK
BMJ, 2015New insights into an old enemy Plasmodium falciparum malaria is so lethal and ubiquitous that one could easily forget that other species of malaria are globally important too. In particular, Plasmodium vivax , the main cause of relapsing malaria, affects up to 300 million people annually, and occurs in far wider and ecologically diverse settings than ...
openaire +3 more sources
Development and validation of serological markers for detecting recent Plasmodium vivax infection
Nature Network Boston, 2020Rhea J. Longley +26 more
semanticscholar +1 more source
Plasmodium vivax: older and wise?
Research in Immunology, 1991V.A. Snewin, S. Longacre, P.H. David
openaire +3 more sources